Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -59.4% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Operating income changed +19.1% from the comparable as-filed period.
Free-cash-flow proxy changed +22.1% from the comparable as-filed period.
Operating cash flow changed +22.3% from the comparable as-filed period.
Research & development changed -88.3% from the comparable as-filed period.
Current assets changed +412.5% from the comparable as-filed period.
Total assets changed +395.7% from the comparable as-filed period.
Working capital / assets changed +4636 basis points from the comparable as-filed period.
Working capital changed +846.2% from the comparable as-filed period.
Current liabilities changed -73.8% from the comparable as-filed period.
Cash & equivalents changed +1009.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Current ratio changed +1859.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Stock-based compensation changed -452.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capital expenditure changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.